TerraVia receives FDA generally recognized as safe letter for Algae Butter
In California, TerraVia Holdings, Inc. received a generally recognized as safe no questions letter from the U.S. Food and Drug Administration for its Algae...
NouriTech breaks ground on new plant to produce Calysta’s FeedKind protein at scale
In Tennessee, NouriTech, a venture formed through investments from Cargill, Calysta, Inc. and several third-party institutions, broke ground on a new thirty-seven acre plant...
The Impossible Burger debuts on the West Coast
In California, Impossible Foods launched the Impossible Burger in selected West Coast restaurants. Not yet available in stores, the Impossible Burger is a result of...
USDA grants a license for the first monoclonal antibody therapy to control canine atopic...
In New Jersey, Zoetis Inc. announced that the U.S. Department of Agriculture granted a license for CYTOPOINT, the first monoclonal antibody therapy approved to...
Impossible Foods to make 1 million pounds of plant-based meat per month
In California, Impossible Foods launched its first large-scale production facility to make at least 1 million pounds of plant-based meat per month – enough...
Drinking sugary beverages every day nearly triples the risk of stroke and dementia
In Massachusetts, researchers reported that Framingham Heart Study data has shown that frequent consumption of sugary beverages such as sodas and fruit juices is...
Red meat has no effect on blood pressure and cholesterol according to Purdue study
In Indiana, Purdue University researchers found that consuming more than the daily recommended intake of red meat does not affect short-term cardiovascular disease risk...
The Beyond Burger goes to Yale
In California, Beyond Meat, announced that its Beyond Burger will be available at Yale University’s thirteen on-campus dining halls; making the 315-year-old Ivy League...
Copia Agro & Food announces a new $50 million agriculture and food investment fund
In Israel, the Copia Agro & Food fund announced it is raising $50 million to expand its investments in agricultural and food projects developed...
BlueRock Therapeutics launches with $225 million from Bayer and Versant Ventures
In Canada, Bayer and Versant Ventures launched BlueRock Therapeutics with a $225 million investment to develop curative therapies based on the latest stem cell...
